Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy for ischemic heart disease.

N Bonaros1, S Yang, H Ott

  • 1Department of Cardiac Surgery, University of Innsbruck, Innsbruck, Austria. nikolaos.bonaros@uibk.ac.at

Panminerva Medica
|July 9, 2004
PubMed
Summary

Cellular therapy shows promise for preventing and treating heart failure, offering new hope for patients. Research explores optimizing cell delivery and survival to improve heart muscle recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Transient numerical simulation of hemodynamics in bioprosthetic heart valves: insights into valve sizing and thrombosis risk.

International journal of computer assisted radiology and surgery·2026
Same author

Early Risk Assessment and Recognition of Allergies in Children: Rationale, Methodology, and Proposed Algorithms.

Allergy·2026
Same author

The development and testing of a smart sensorized guide wire for catheterization in a "blood" vessel phantom to support aortic valve implementation.

International journal of computer assisted radiology and surgery·2024
Same author

Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.

European heart journal·2022
Same author

Identification of compound heterozygous mutations in AP1B1 leading to the newly described recessive keratitis-ichthyosis-deafness (KIDAR) syndrome.

The British journal of dermatology·2021

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Biology

Background:

  • Heart failure remains a leading cause of mortality, with over 50% of patients dying within five years of diagnosis despite current treatments.
  • Functional restoration of the damaged heart is a significant challenge, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

  • To review the current status of cellular therapy for heart failure.
  • To explore the potential of cell-based approaches for preventing and treating heart failure.
  • To discuss prospects for clinical implementation of cellular therapies.

Main Methods:

  • Review of recent research on various cell types, including stem cells, skeletal myoblasts, fetal cardiomyocytes, and fibroblasts.
  • Analysis of strategies for preventing post-infarction heart failure.

Related Experiment Videos

  • Examination of cell delivery, homing, and survival in the myocardium.

    • Main Results:

    • Several cell lines demonstrate potential for preventing and treating heart failure.
    • Cellular therapies may promote new blood vessel formation (angiogenesis) and replace damaged heart muscle cells.
    • Optimizing cell delivery, homing, and survival is crucial for myocardial recovery.

    Conclusions:

    • Cellular therapy presents a promising avenue for heart failure management.
    • Further research is needed to optimize cell-based strategies for clinical application.
    • Successful implementation could significantly improve outcomes for patients with heart failure.